Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients

Blood

Volumn 99, Issue 3, 2002, Pages 840-849

  Onida, Francesco ^a   Kantarjian, Hagop M ^a   Smith, Terry L ^a   Ball, Greg ^a   Keating, Michael J ^a   Estey, Elihu H ^a   Glassman, Armand B ^a   Albitar, Maher ^a   Kwari, Monica I ^a   Beran, Miloslav ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; DISEASE COURSE; DISEASE MODEL; DRUG EFFICACY; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0036464647     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.3.840     Document Type: Article

References (50)

1. Haematological classification of the chronic myeloid leukaemias
2. Hematological differences between chronic granulocytic leukemia, atypical chronic myeloid leukemia and chronic myelomonocytic leukemia
3. Chronic myelomonocytic leukaemia (CMML) - A myelodysplastic or myelo-proliferative syndrome?
4. The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group
5. Mixed myelodysplastic and myeloproliferative syndromes
6. A diagnostic dilemma: Chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia. A case report and review of the literature
7. The myelodysplastic syndromes: Towards a functional classification
8. The classification of chronic myelomonocytic leukaemia
9. Problems in the classification of CMML - Dysplastic versus proliferative type
10. Proposals for the classification of the myelodysplastic syndromes
11. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997
12. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report of 408 cases
13. Chronic myelomonocytic leukemia according to FAB classification: Analysis of 35 cases
14. Myelo-dysplastic syndromes: A scoring system with prognostic significance
15. Chronic myelomonocytic leukemia: Clinical features, cytogenetics, and prognosis in 30 consecutive cases
16. Chronic and subacute myelomonocytic leukemia in the adult: A report of 60 cases with special reference to prognostic factors
17. Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML)
18. Myelodysplastic syndromes: Analysis of clinical and prognostic features in 96 patients
19. Prognostic factors in chronic myelodysplastic syndromes: A multivariate analysis in 107 cases
20. Prognostic factors in adult chronic myelomono-cytic leukemia: An analysis of 107 cases
21. Prognostic features of chronic myelomonocytic leukaemia: A modified Bournemouth score gives the best prediction of survival
22. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients
23. Chronic myelomonocytic leukemia - Clinicobiological characteristics: A multivariate analysis in a series of 70 cases
24. Chronic myelomonocytic leukemia: Natural history and prognostic determinants
25. Chronic myelomonocytic leukemia
26. Prognostic factors of myelodysplastic syndromes: A simplified 3-D scoring system
27. Chronic myelomonocytic leukemia: Single entity or heterogeneous disorder? A prospective multicenter study of 100 patients
28. Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system
29. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: A multi-centric study in Japan
30. Prognosis of chronic myelomonocytic leukemia
31. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia
32. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: A chronic myeloid leukemia with a distinct clinical course
33. Regression models and life tables
34. Martingale-based residuals for survival models
35. International scoring system for evaluating prognosis in myelodysplastic syndromes
36. Diagnosis, classification, and cytogenetics of myelodysplastic syndromes
37. A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria
38. Cytogenetics of chronic myelomonocytic leukemia
39. Prognostic value of pretreatment serum β 2-microglobulin in myeloma: A Southwest Oncology Group Study
40. A new serologic staging system for large cell lymphomas based on initial β 2-microglobulin and lactate dehydrogenase levels
41. Chronic lymphocytic leukemia
42. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5; 12) chromosomal translocation
43. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
44. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor β receptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33; q11.2)
45. Transformation of hematopoietic cell lines to growth factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
46. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3